Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

“The Medical Aesthetics industry is continuously evolving, with GLP-1 medications fundamentally reshaping how aesthetic practices approach patient acquisition and revenue generation,” said ...

Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has published in JAMA Network Open, offering critical ...

The best way to know if a medication is right for you is to consult your preferred medical provider. Tenpas cautions against using compounded versions of GLP-1 medications that are not approved by ...

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...

IFT weighed in on the Dietary Guidelines for Americans with its recommendations in collaboration with the American Society of Nutrition. 3. Food is Medicine receives a stronger push and greater ...

Al-Aly said. He was surprised, when he searched the medical literature, that this finding hadn’t come out of the blue. There have been some studies suggesting that GLP-1 medications reduce ...